Literature DB >> 8840126

Functional analysis of opioid receptor subtypes in the ventromedial hypothalamic nucleus of the rat.

C Zhang1, D W Pfaff, L M Kow.   

Abstract

Effects of [Met5]enkephalin and agonists selective for mu-, delta- and kappa-opioid receptors were tested in vitro on neurons of the hypothalamic ventromedial nucleus of ovariectomized, estrogen-primed rats. Brain slices were perfused with artificial cerebrospinal fluid and opioid drugs were applied by bolus injection into the perfusion line. Single unit activity was recorded extracellularly. The majority of ventromedial hypothalamic nucleus neurons tested exhibited marked inhibitory responses to [Met5]enkephalin. The inhibition was blocked by naloxone, by the selective delta-opioid receptor antagonist naltrindole and, to a lesser extent, by the mu-opioid receptor antagonist beta-funaltrexamine. The kappa-opioid receptor antagonist nor-binalmorphimine had virtually no effect on [Met5]enkephalin inhibition. Agonists selective for delta-([D-Pen2,D-Pen5]enkephalin, DPDPE) and for mu-([D-Ala2,MePhe4,Gly-ol5]enkephalin, DAGO) opioid receptors also potently inhibited the ventromedial hypothalamic nucleus neurons while the kappa-opioid receptors agonist U50,488 only produced a small inhibition in a smaller number of units. These results provide functional evidence that [Met5]enkephalin, a potential opioid transmitter in the ventromedial hypothalamic nucleus, can exert an inhibitory effect by acting on delta-and mu-opioid receptors.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8840126     DOI: 10.1016/0014-2999(96)00293-2

Source DB:  PubMed          Journal:  Eur J Pharmacol        ISSN: 0014-2999            Impact factor:   4.432


  8 in total

1.  Opioid receptor blockade improves hypoglycemia-associated autonomic failure in type 1 diabetes mellitus.

Authors:  Septimiu Vele; Sofiya Milman; Harry Shamoon; Ilan Gabriely
Journal:  J Clin Endocrinol Metab       Date:  2011-09-14       Impact factor: 5.958

2.  Pre- and postsynaptic actions of opioid and orphan opioid agonists in the rat arcuate nucleus and ventromedial hypothalamus in vitro.

Authors:  P J Emmerson; R J Miller
Journal:  J Physiol       Date:  1999-06-01       Impact factor: 5.182

3.  Magnitude of exercise-induced β-endorphin response is associated with subsequent development of altered hypoglycemia counterregulation.

Authors:  Sofiya Milman; James Leu; Harry Shamoon; Septimiu Vele; Ilan Gabriely
Journal:  J Clin Endocrinol Metab       Date:  2011-12-14       Impact factor: 5.958

4.  Cocaine withdrawal-induced trafficking of delta-opioid receptors in rat nucleus accumbens.

Authors:  Lisa M Ambrose-Lanci; Niluk B Peiris; Ellen M Unterwald; Elisabeth J Van Bockstaele
Journal:  Brain Res       Date:  2008-03-15       Impact factor: 3.252

Review 5.  Central Mechanisms of Glucose Sensing and Counterregulation in Defense of Hypoglycemia.

Authors:  Sarah Stanley; Amir Moheet; Elizabeth R Seaquist
Journal:  Endocr Rev       Date:  2019-06-01       Impact factor: 19.871

6.  Naltrexone for treatment of impaired awareness of hypoglycemia in type 1 diabetes: A randomized clinical trial.

Authors:  Amir Moheet; Silvia Mangia; Anjali Kumar; Nolawit Tesfaye; Lynn E Eberly; Yun Bai; Kristine Kubisiak; Elizabeth R Seaquist
Journal:  J Diabetes Complications       Date:  2015-08-12       Impact factor: 2.852

7.  Opioid receptor blockade prevents exercise-associated autonomic failure in humans.

Authors:  Sofiya Milman; James Leu; Harry Shamoon; Septimiu Vele; Ilan Gabriely
Journal:  Diabetes       Date:  2012-04-20       Impact factor: 9.461

8.  Opioid Receptor Activation Impairs Hypoglycemic Counterregulation in Humans.

Authors:  Michelle Carey; Rebekah Gospin; Akankasha Goyal; Nora Tomuta; Oana Sandu; Armand Mbanya; Eric Lontchi-Yimagou; Raphael Hulkower; Harry Shamoon; Ilan Gabriely; Meredith Hawkins
Journal:  Diabetes       Date:  2017-08-31       Impact factor: 9.461

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.